MEK Inhibitors

查看全部
Product Name MEK1 MEK2 MEK5 MEK MAP2K4/MEK4 MAP2K7/MEK7 Purity
(2Z,3Z)-U0126
(E/Z)-Chk2-IN-1
(R)-PD 0325901CL
3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles 99.84%
5-O-Methylvisammioside 99.90%
AKT-IN-24
AKT1-IN-13
Anti-MP1 Antibody
Anticancer agent 164
APS-2-79 99.38%
APS-2-79 hydrochloride 98.42%
Aspartyl-alanyl-diketopiperazine 98.87%
Atebimetinib 99.55%
ATWLPPRAANLLMAAS
Avutometinib 99.43%
Avutometinib potassium
AZD8330 99.05%
Balamapimod 99.47%
BAY-866
BI-847325 98.30%
Binimetinib 99.92%
Binimetinib-d3
Binimetinib-d4
BIX02188 98.10%
BIX02189 99.72%
BJG-05-039 98.06%
BRAFV600E/JNK-IN-1
Broussoflavonol F 95.49%
C16-PAF 99.15%
Cefotetan 98.52%
CHMFL-EGFR-202 99.75%
CI-1040 99.91%
CI-1040 hydrochloride
CS640 99.48%
Debromohymenialdisine
DS03090629 99.16%
DZ2002 99.83%
EBI-1051
Envometinib
Ferroptosis inducer-7
G-479
G-963
GDC-0623 98.74%
GIT1-IN-1
Gossypetin 99.0%
Grb2 SH2 domain inhibitor 1 98.24%
GSK1790627 99.08%
GW284543 99.94%
GW284543 hydrochloride
HDB-1 98.02%
HRS-4642 98.38%
IK-595 98.55%
JTP-70902
KRAS G12D-IN-30 99.38%
KZ-02
L-783277
Lidocaine
Lixisenatide 99.84%
LLS30
LP-65
LQEQ-19 (mouse, rat)
Luvometinib 99.94%
Luvometinib-d
MAP2K1 Human Pre-designed siRNA Set A
MAP2K1 L115P Recombinant Human Active Protein Kinase
Map2k1 Mouse Pre-designed siRNA Set A
MAP2K1 P124L Recombinant Human Active Protein Kinase
Map2k1 Rat Pre-designed siRNA Set A
MAP2K2 Human Pre-designed siRNA Set A
Map2k2 Mouse Pre-designed siRNA Set A
Map2k2 Rat Pre-designed siRNA Set A
MAP2K2 Recombinant Human Active Protein Kinase
MAP2K5 Human Pre-designed siRNA Set A
Map2k5 Mouse Pre-designed siRNA Set A
Map2k5 Rat Pre-designed siRNA Set A
MAP855 98.37%
MARY1
MEK inhibitor 98.35%
MEK ligand-2
MEK-IN-1
MEK-IN-10
MEK-IN-4
MEK-IN-5
MEK-IN-7
MEK-IN-8
MEK-IN-9
MEK/PI3K-IN-1
MEK/PI3K-IN-2
MEK/RAF-IN-1
MEK1 Derived Peptide Inhibitor 1
MEK1 F53L Recombinant Human Active Protein Kinase
MEK1 ligand-1
MEK1 P124L Recombinant Human Active Protein Kinase
MEK1 SESE Recombinant Human Active Protein Kinase
MEK1-IN-1
MEK1/2-IN-2
MEK1/C-Raf-IN-1
MEK4 IN-3
MEK4 IN-4
MEK4 inhibitor-1 98.89%
MEK4 inhibitor-2
MEK5 Recombinant Human Active Protein Kinase
Mirdametinib 99.95%
Mirdametinib
ML175 99.37%
MO-2097
MS432 99.72%
MS910
MS934 98.48%
Napyradiomycin B4
Nedometinib 98.09%
NEPP11
NST-628 99.35%
PD 198306 99.75%
PD 198306 (Standard)
PD-254552
PD-334581 99.72%
PD-334581 (Standard)
PD0325901-O-C2-dioxolane 98.62%
PD184161 98.08%
PD318088 99.82%
PD98059 99.27%
PHI-501
Pimasertib 99.60%
Pimasertib hydrochloride
Pipoxolan
Polfurmetinib 98.21%
Polfurmetinib hydrate
PQ-1
PROTAC FLT-3 degrader 1 98.26%
PROTAC HIF-1α degrader-2
PROTAC MEK1 Degrader-1 98.03%
Refametinib 99.82%
Refametinib (R enantiomer)
RGB-286638 99.67%
RGB-286638 free base 98.09%
RO 4927350
RO4987655 99.01%
RO5068760
SAR125844 98.17%
Saucerneol
Selumetinib sulfate 99.58%
SHOC2-RAS PPI-IN-1 99.50%
SHY-855 98.54%
SHY-867
SIJ1777
SJ-C1044 98.63%
SL327 99.57%
SL43
SMK-17
ST-168
STK899704
TAK-733 99.79%
TERT activator-1 99.91%
Trametiglue 98.81%
TriDAP
TriDAP dihydrochloride 98.65%
Trilinolein 98.0%
Trilinolein-13C54
Trilinolein-d5
TRX-COBI
Tunlametinib 99.53%
U0124 98.0%
U0124 (Standard)
U0126 98.57%
U0126-EtOH 98.66%
UBX-382 96.20%
X-370
Z-FF-FMK 95.98%
Zapnometinib 99.85%
Notoginsenoside R2 99.80%
Lixisenatide (Leu-13C6,15N) TFA
Lidocaine-d10 98.89%
N-Oxide Lidocaine-d10
Lidocaine (Standard) 99.97%
Lidocaine-d6
Lidocaine 99.96%
Demethylwedelolactone 99.89%
trans-Zeatin 99.77%
trans-Zeatin-d5 99.2%
Selumetinib 99.56%
Rehmannioside A 99.95%
Hypothemycin 98.0%
Hexestrol-d4
Isorhamnetin 99.74%
Isorhamnetin (Standard) 98%
Trametinib 99.93%
Trametinib-13C6
Trametinib-d4 99.87%
Trametinib-13C,d3
Trametinib (DMSO solvate) 99.50%
Sophocarpine 99.85%
Sophocarpine monohydrate 99.91%
Flurbiprofen axetil 99.34%
Lanthanum(Ⅲ) chloride 99.99%
Polygalasaponin F 99.85%
Glycinexylidide 95.06%
Sorafenib tosylate 99.98%
Lidocaine hydrochloride 99.84%
Lidocaine-d10 hydrochloride 99.55%
Lidocaine-d6 hydrochloride
Lidocaine hydrochloride hydrate 99.80%
Anemarsaponin B 99.43%
Sorafenib 99.84%
Cobimetinib (R-enantiomer) 99.86%
Cobimetinib racemate 99.39%
Cobimetinib-13C6 racemate
Cobimetinib 99.81%
Cobimetinib hemifumarate 99.68%
Cobimetinib-d4 hydrochloride 99.26%
Cucurbitacin IIa 99.90%
Simetryn 99.75%
Lixisenatide acetate 99.11%
Azelnidipine 99.79%

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础